Invesco Ltd. Has $7.38 Million Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Invesco Ltd. raised its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 243,311 shares of the company’s stock after acquiring an additional 13,224 shares during the quarter. Invesco Ltd. owned about 0.26% of Acadia Healthcare worth $7,377,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Covestor Ltd raised its position in shares of Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company’s stock valued at $69,000 after purchasing an additional 812 shares during the period. Zions Bancorporation National Association UT bought a new position in shares of Acadia Healthcare in the first quarter valued at approximately $491,000. Wolverine Asset Management LLC bought a new position in shares of Acadia Healthcare in the first quarter valued at approximately $933,000. Citigroup Inc. raised its position in shares of Acadia Healthcare by 5,144.2% in the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock valued at $72,047,000 after purchasing an additional 2,330,898 shares during the period. Finally, Headlands Technologies LLC raised its position in shares of Acadia Healthcare by 6,982.6% in the first quarter. Headlands Technologies LLC now owns 25,993 shares of the company’s stock valued at $788,000 after purchasing an additional 25,626 shares during the period.

Acadia Healthcare Stock Down 1.2%

ACHC opened at $22.17 on Tuesday. Acadia Healthcare Company, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $82.40. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The firm’s fifty day moving average price is $21.94 and its two-hundred day moving average price is $25.87. The company has a market capitalization of $2.05 billion, a P/E ratio of 14.68, a P/E/G ratio of 4.42 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. During the same quarter in the previous year, the company earned $0.91 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

ACHC has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Sunday, August 3rd. Guggenheim dropped their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. UBS Group dropped their target price on shares of Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Stephens raised shares of Acadia Healthcare to a “hold” rating in a research report on Monday, June 2nd. Finally, Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Nine equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $40.77.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.